Drug General Information (ID: DDICZEO56N)
  Drug Name Aldesleukin Drug Info Zaleplon Drug Info
  Drug Type Interferons Small molecule
  Therapeutic Class Antineoplastics Anxiolytics/Sedatives/Hypnotics

 Mechanism of Aldesleukin-Zaleplon Interaction (Severity Level: Moderate)
     Additive CNS depression effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Aldesleukin Zaleplon
      Mechanism CNS depression effects CNS depression effects
      Key Mechanism Factor 1
Factor Name CNS depression effects
Factor Description CNS depressants are drugs that inhibit or suppress brain activity and can reduce mental and physical processes. Excessive CNS depression can lead to decreased heart rate, slow breathing (less than 10 breaths per minute), extreme confusion or loss of memory, nausea and vomiting, poor judgment, blue lips or fingertips, irritability and aggression, and clammy or cold skin.
      Mechanism Description
  • Additive CNS depression effects by the combination of Aldesleukin and Zaleplon 

Recommended Action
      Management Caution is advised if aldesleukin is used with sedatives, hypnotics, tranquilizers, or other CNS-active medications. Patients should be monitored for CNS depression and other CNS adverse effects. Treatment with aldesleukin should be discontinued if severe lethargy or somnolence develop.

References
1 Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
2 Product Information. Proleukin (aldesleukin). Chiron Therapeutics, Emeryville, CA.
3 Cerner Multum, Inc. "UK Summary of Product Characteristics.".